←Back to Expert Scholars
Translational Medicine / 转化医学Drug Repurposing, Adaptive Trial Design
Donald Berry
PhD
🏢MD Anderson Cancer Center🌐USA
Professor of Biostatistics
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Donald Berry pioneered Bayesian adaptive platform trials like I-SPY that accelerate evaluation of repurposed and novel agents. His methods underpin efficient testing of repurposing candidates in breast and other cancers. He leads biostatistics at MD Anderson.
Share:
🧪Research Fields 研究领域
Bayesian adaptive design
platform trials
I-SPY
repurposing
biostatistics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Donald Berry 的研究动态
Follow Donald Berry's research updates
留下邮箱，当我们发布与 Donald Berry（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment